Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Cancer drugs often cause temporary hair, skin, nail, and mouth issues.

New nanocarriers improve drug delivery for disease treatment.

Nanomaterials can improve hair care products and treatments, including hair loss and alopecia, by enhancing stability and safety, and allowing controlled release of compounds, but their safety in cosmetics needs more understanding.

CBD may improve skin and hair health, but its effective use and safety need more research.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Injectable hydrogels are becoming increasingly useful in medicine for drug delivery and tissue repair.

Some cancer treatments cause different types of hair loss, but scalp cooling can help prevent it.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

Hair follicles have a more inactive cell cycle than other skin cells, which may help develop targeted therapies for skin diseases and cancer.

Skin reactions from cancer treatments might predict how well the treatments work.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Paclitaxel is an effective cancer drug with side effects and potential new uses beyond cancer.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Egyptian researchers are advancing in pharmaceutical nanotechnology, potentially improving health outcomes and the economy.

New nanoparticles deliver plant extracts to hair follicles to treat conditions like hair loss and acne.